Ramona Sequeira, President, United States Business Unit, is responsible for the company’s commercial operations in the U.S. She serves as a member of Takeda’s Executive Team.
Prior to joining Takeda, Ms. Sequeira held various senior roles of increasing responsibility at Eli Lilly, both in the U.S. and the U.K. During her career, she led several successful product launches, managed relationships with partners, improved operational performance and workforce engagement. In her role as General Manager, U.K. Hub, she had responsibility for all affiliate operations in the U.K., Republic of Ireland and Northern Europe. She was a member of the Association of the British Pharmaceutical Industry.
Ms. Sequeira is a member of the PhRMA Board of Directors. PhRMA is the Pharmaceutical Research and Manufacturers of America, representing the country’s leading biopharmaceutical researchers and biotechnology companies. Additionally, Ms. Sequeira is a board member of the Healthcare Leadership Council, a coalition of executives from all disciplines within American healthcare. It is the exclusive forum for the nation’s healthcare leaders to jointly develop policies, plans, and programs to achieve their vision of a 21st century system that makes affordable, high-quality care accessible to all Americans.
Ms. Sequeira received a B.S. with honors in molecular genetics and molecular biology from the University of Toronto, and later received an MBA from McMaster University in Canada.